<?xml version="1.0" encoding="UTF-8"?>
<p>Bacillus Calmette–Guérin (BCG) vaccine is widely used in infancy as prevention against tuberculosis (TB). Epidemiological and randomized studies suggest that BCG vaccine provides a protective effect against infant mortality through nonspecific heterologous protection to other infections
 <sup>
  <xref rid="cit0015" ref-type="bibr">15</xref>
 </sup> maybe through innate immune epigenetic mechanisms.
 <sup>
  <xref rid="cit0015" ref-type="bibr">15</xref>–
  <xref rid="cit0017" ref-type="bibr">17</xref>
 </sup> Exposure to BCG vaccine can reduce the severity of COVID-19 and may lower mortality, and thus, it may be helpful in development of therapeutic or preventive strategies that can impact SARS-CoV-2 infections.
</p>
